Metraipolis › archive › dc_e4679ee24df5

Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial — Europe PMC PMID:41605963

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41605963
DOI
10.1038/s41523-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-06T11:47:41.401Z
SHA-256 of the archived text
11d004b485fc3e6bf2fe463e5466b8c2f3e9f5f4a1e5d9fce3d02802c387d570
Stable URL of this page
https://metraipolis.com/documento/dc_e4679ee24df5

How to cite

Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial — Europe PMC PMID:41605963 — Europe PMC (en), https://europepmc.org/article/MED/41605963 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4679ee24df5 (Metraipolis archive dc_e4679ee24df5, sha256 11d004b485fc3e6bf2fe463e5466b8c2f3e9f5f4a1e5d9fce3d02802c387d570)
BibTeX
@misc{dce4679ee24df5,
  title = {Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial — Europe PMC PMID:41605963},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41605963},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4679ee24df5; sha256 11d004b485fc3e6bf2fe463e5466b8c2f3e9f5f4a1e5d9fce3d02802c387d570},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41605963. Agents can read the archived copy with the MCP tool read_document.